Atomistry » Magnesium » PDB 5w51-5whb » 5wg3
Atomistry »
  Magnesium »
    PDB 5w51-5whb »
      5wg3 »

Magnesium in PDB 5wg3: Human GRK2 in Complex with Gbetagamma Subunits and CCG258748

Enzymatic activity of Human GRK2 in Complex with Gbetagamma Subunits and CCG258748

All present enzymatic activity of Human GRK2 in Complex with Gbetagamma Subunits and CCG258748:
2.7.11.15;

Protein crystallography data

The structure of Human GRK2 in Complex with Gbetagamma Subunits and CCG258748, PDB code: 5wg3 was solved by R.Bouley, J.J.G.Tesmer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 49.07 / 2.90
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 61.267, 241.569, 214.813, 90.00, 90.00, 90.00
R / Rfree (%) 19.8 / 24.8

Other elements in 5wg3:

The structure of Human GRK2 in Complex with Gbetagamma Subunits and CCG258748 also contains other interesting chemical elements:

Fluorine (F) 1 atom

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Human GRK2 in Complex with Gbetagamma Subunits and CCG258748 (pdb code 5wg3). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Human GRK2 in Complex with Gbetagamma Subunits and CCG258748, PDB code: 5wg3:

Magnesium binding site 1 out of 1 in 5wg3

Go back to Magnesium Binding Sites List in 5wg3
Magnesium binding site 1 out of 1 in the Human GRK2 in Complex with Gbetagamma Subunits and CCG258748


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Human GRK2 in Complex with Gbetagamma Subunits and CCG258748 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg702

b:0.2
occ:1.00
O A:GLU360 2.1 0.7 1.0
O A:GLN363 2.5 1.0 1.0
O A:VAL366 2.6 0.3 1.0
O A:HIS348 2.7 1.0 1.0
O A:VAL361 3.2 0.3 1.0
C A:GLU360 3.2 0.2 1.0
CE2 A:TYR368 3.4 0.7 1.0
CD2 A:TYR368 3.4 0.6 1.0
CA A:VAL361 3.5 0.3 1.0
C A:GLN363 3.5 0.9 1.0
C A:VAL361 3.5 0.9 1.0
C A:HIS348 3.6 0.5 1.0
C A:VAL366 3.7 0.7 1.0
N A:VAL361 3.8 1.0 1.0
CA A:HIS348 4.0 0.1 1.0
N A:VAL366 4.0 0.9 1.0
CB A:VAL366 4.1 0.2 1.0
CA A:VAL366 4.2 0.3 1.0
N A:GLN363 4.2 0.6 1.0
CA A:GLN363 4.3 0.8 1.0
N A:LYS364 4.4 0.1 1.0
CA A:GLU360 4.4 0.9 1.0
CB A:HIS348 4.5 0.8 1.0
CA A:LYS364 4.5 0.5 1.0
N A:LEU362 4.5 0.2 1.0
CB A:GLN363 4.7 0.4 1.0
CZ A:TYR368 4.7 0.2 1.0
N A:GLY365 4.7 0.8 1.0
CG A:TYR368 4.7 0.7 1.0
C A:LEU362 4.8 0.6 1.0
N A:ALA349 4.8 0.8 1.0
CG1 A:VAL366 4.8 0.0 1.0
N A:ALA367 4.9 0.2 1.0
O A:ALA349 4.9 0.4 1.0
CB A:VAL361 4.9 0.6 1.0
C A:LYS364 4.9 0.3 1.0
CB A:GLU360 5.0 0.2 1.0
C A:ALA349 5.0 0.5 1.0

Reference:

R.Bouley, H.V.Waldschmidt, M.C.Cato, A.Cannavo, J.Song, J.Y.Cheung, X.Q.Yao, W.J.Koch, S.D.Larsen, J.J.G.Tesmer. Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 Inhibitors. Mol. Pharmacol. V. 92 707 2017.
ISSN: ESSN 1521-0111
PubMed: 29070696
DOI: 10.1124/MOL.117.110130
Page generated: Mon Sep 30 06:34:24 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy